Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Kinetic modelling of serum S100b after traumatic brain injury.

Ercole A, Thelin EP, Holst A, Bellander BM, Nelson DW.

BMC Neurol. 2016 Jun 17;16:93. doi: 10.1186/s12883-016-0614-3.

2.

Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury.

Thompson WH, Thelin EP, Lilja A, Bellander BM, Fransson P.

Neuroimage Clin. 2016 May 9;12:1004-1012. eCollection 2016.

3.

Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.

Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander BM, Nelson DW.

Crit Care. 2016 Sep 8;20:285. doi: 10.1186/s13054-016-1450-y.

4.

Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, Papa L.

J Neurotrauma. 2017 Jun 1;34(11):1957-1971. doi: 10.1089/neu.2016.4772. Epub 2017 Feb 27.

PMID:
28031000
5.

Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?

Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B.

J Forensic Leg Med. 2018 Apr;55:65-73. doi: 10.1016/j.jflm.2018.02.016. Epub 2018 Feb 14.

PMID:
29471249
6.

Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.

Thelin EP, Nelson DW, Bellander BM.

Neurocrit Care. 2014 Apr;20(2):217-29. doi: 10.1007/s12028-013-9916-0.

PMID:
24146416
7.

Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.

Kellermann I, Kleindienst A, Hore N, Buchfelder M, Brandner S.

Clin Neurol Neurosurg. 2016 Jun;145:79-83. doi: 10.1016/j.clineuro.2016.04.005. Epub 2016 Apr 8.

PMID:
27101088
8.

Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.

Park SH, Hwang SK.

World Neurosurg. 2018 Oct;118:e534-e542. doi: 10.1016/j.wneu.2018.06.234. Epub 2018 Jul 6.

PMID:
30257306
9.

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.

Rainey T, Lesko M, Sacho R, Lecky F, Childs C.

Resuscitation. 2009 Mar;80(3):341-5. doi: 10.1016/j.resuscitation.2008.11.021. Epub 2009 Jan 15.

PMID:
19150161
10.

S100B is an important outcome predictor in traumatic brain injury.

Thelin EP, Johannesson L, Nelson D, Bellander BM.

J Neurotrauma. 2013 Apr 1;30(7):519-28. doi: 10.1089/neu.2012.2553. Epub 2013 Apr 15.

PMID:
23297751
11.

S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.

Goyal A, Failla MD, Niyonkuru C, Amin K, Fabio A, Berger RP, Wagner AK.

J Neurotrauma. 2013 Jun 1;30(11):946-57. doi: 10.1089/neu.2012.2579.

12.

S100B protein may detect brain death development after severe traumatic brain injury.

Egea-Guerrero JJ, Murillo-Cabezas F, Gordillo-Escobar E, Rodríguez-Rodríguez A, Enamorado-Enamorado J, Revuelto-Rey J, Pacheco-Sánchez M, León-Justel A, Domínguez-Roldán JM, Vilches-Arenas A.

J Neurotrauma. 2013 Oct 15;30(20):1762-9. doi: 10.1089/neu.2012.2606. Epub 2013 Aug 28.

13.

Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers.

Dadas A, Washington J, Marchi N, Janigro D.

Fluids Barriers CNS. 2016 Nov 30;13(1):21. doi: 10.1186/s12987-016-0045-y.

14.

S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Gordillo-Escobar E, Enamorado-Enamorado J, Hernández-García C, Ruiz de Azúa-López Z, Vilches-Arenas Á, Guerrero JM, Murillo-Cabezas F.

Neurol Res. 2016 Feb;38(2):130-7. doi: 10.1080/01616412.2016.1144410. Epub 2016 Mar 4.

PMID:
27078699
15.

Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.

Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.

Clin Lab. 2011;57(7-8):587-97.

PMID:
21888023
16.

The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with s100b in severe traumatic brain injury.

Walder B, Robin X, Rebetez MM, Copin JC, Gasche Y, Sanchez JC, Turck N.

J Neurotrauma. 2013 Oct 1;30(19):1631-7. doi: 10.1089/neu.2012.2791.

PMID:
23590685
17.

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.

Al Nimer F, Thelin E, Nyström H, Dring AM, Svenningsson A, Piehl F, Nelson DW, Bellander BM.

PLoS One. 2015 Jul 2;10(7):e0132177. doi: 10.1371/journal.pone.0132177. eCollection 2015.

18.

S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.

Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dressler J.

J Neurotrauma. 2013 Nov 15;30(22):1862-71. doi: 10.1089/neu.2013.2895. Epub 2013 Sep 19.

PMID:
23796187
19.

Serum S100B Levels Can Predict Computed Tomography Findings in Paediatric Patients with Mild Head Injury.

Kelmendi FM, Morina AA, Mekaj AY, Blyta A, Alimehmeti R, Dragusha S, Ahmeti F, Morina Q, Kotori A.

Biomed Res Int. 2018 Apr 23;2018:6954045. doi: 10.1155/2018/6954045. eCollection 2018.

20.

Assessing bicycle-related trauma using the biomarker S100B reveals a correlation with total injury severity.

Thelin EP, Zibung E, Riddez L, Nordenvall C.

Eur J Trauma Emerg Surg. 2016 Oct;42(5):617-625. Epub 2015 Oct 21.

PMID:
26490563

Supplemental Content

Support Center